Clinical Trial Update: Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer [Phase 1]

View source ↗

Summary

Amal Therapeutics reports a Phase 1b trial evaluating ATP128, VSV-GP128, and BI 754091 in patients with stage IV/metastatic colorectal cancer; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ATP128
• BI-754091
• VSV-GP128

Snippet

Sponsor: Amal Therapeutics | Conditions: Colorectal Cancer, MSS | Phase 1 | Status: ACTIVE_NOT_RECRUITING